The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126255614 12625561 4 F 20160623 20160816 20160805 20160823 EXP PHHY2016FR104795 ALCON 70.18 YR M Y 0.00000 20160823 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126255614 12625561 1 PS VALSARTAN SANDOZ VALSARTAN 1 Oral 160 MG, QD 0 160 MG FILM-COATED TABLET QD
126255614 12625561 2 SS AMOXICILLINE/ACIDE CLAVULANIQUE SANDOZ AMOXICILLINCLAVULANIC ACID 1 Oral 1 G, TID 18 G 0 1 G TID
126255614 12625561 3 SS OFLOXACIN SANDOZ OFLOXACIN 1 Oral 200 MG, BID 2400 MG 0 200 MG FILM-COATED TABLET BID
126255614 12625561 4 SS KETOPROFENE MYLAN KETOPROFEN 1 Oral 100 MG, BID 1200 MG 0 100 MG BID
126255614 12625561 5 SS ESOMEPRAZOLE MYLAN//ESOMEPRAZOLE ESOMEPRAZOLE 1 Oral 20 MG, QD 120 MG 0 20 MG QD
126255614 12625561 6 SS SKENAN MORPHINE SULFATE 1 Oral 10 MG, BID 120 MG 0 10 MG BID
126255614 12625561 7 SS MORPHINE SULFATE. MORPHINE SULFATE 1 Oral 10 MG, PRN 60 MG 0 10 MG
126255614 12625561 8 C DETENSIEL BISOPROLOL FUMARATE 1 Unknown 10 MG, QD U 0 10 MG QD
126255614 12625561 9 C KARDEGIC ASPIRIN LYSINE 1 Unknown 1 DF, QD U 0 1 DF QD
126255614 12625561 10 C METFORMIN METFORMIN HYDROCHLORIDE 1 Unknown 1000 MG, TID U 0 1000 MG TID
126255614 12625561 11 C ALLOPURINOL. ALLOPURINOL 1 Unknown 200 MG, TID U 0 200 MG TID
126255614 12625561 12 C FENOFIBRATE. FENOFIBRATE 1 Unknown 145 MG, QD U 0 145 MG QD
126255614 12625561 13 C PERMIXON SAW PALMETTO 1 Unknown 2 DF, QD U 0 2 DF QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126255614 12625561 1 Hypertension
126255614 12625561 2 Lung disorder
126255614 12625561 3 Product used for unknown indication
126255614 12625561 4 Spinal pain
126255614 12625561 5 Prophylaxis against gastrointestinal ulcer
126255614 12625561 6 Spinal pain
126255614 12625561 7 Spinal pain
126255614 12625561 8 Product used for unknown indication
126255614 12625561 9 Product used for unknown indication
126255614 12625561 10 Product used for unknown indication
126255614 12625561 11 Product used for unknown indication
126255614 12625561 12 Product used for unknown indication
126255614 12625561 13 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126255614 12625561 HO
126255614 12625561 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
126255614 12625561 Acute kidney injury

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126255614 12625561 1 20160623 0
126255614 12625561 2 20160618 20160623 0
126255614 12625561 3 20160618 20160623 0
126255614 12625561 4 20160618 20160623 0
126255614 12625561 5 20160618 20160623 0
126255614 12625561 6 20160618 20160623 0
126255614 12625561 7 20160618 20160623 0